Clinical Oral Investigations

, Volume 22, Issue 7, pp 2511–2518 | Cite as

Lactobacillus rhamnosus intake can prevent the development of Candidiasis

  • Mariella Vieira Pereira LeãoEmail author
  • Talita Angelina Aureliano Tavares
  • Célia Regina Gonçalves e Silva
  • Silvana Soleo Ferreira dos Santos
  • Juliana Campos Junqueira
  • Luciane Dias de Oliveira
  • Antonio Olavo Cardoso Jorge
Original Article



This study aimed to investigate the influence of Lactobacillus rhamnosus intake on the development of candidiasis and cytokines release.

Material and methods

Candida suspensions were inoculated into the oral cavity of experimentally immunosuppressed mice for candidiasis induction. The animals were divided into experimental groups: candidiasis with no probiotic intake (F), candidiasis with probiotic intake during Candida inoculation (FP), and candidiasis with probiotic intake 14 days before inoculation with Candida (FPP); and control groups: (C), (CP), and (CPP) without inducing candidiasis with probiotic intake in the same manner as groups F, FP, and FPP, respectively. After these periods, samples were collected from the oral cavity for yeast counts and, after euthanasia, the tongues of the animals were removed for histological analysis. Sera samples were also collected for analysis of IL-1 beta, TNF-alpha, INF-gamma, IL-12, IL-4, and IL-10.


FP group showed lower Candida counts in the oral cavity, and the presence of Candida was almost not detected in FPP group. In tissues, the counts of fungi were significantly lower in FPP group, followed by FP. Groups that consumed probiotics also had lower histological and inflammatory infiltrates compared to F. Cytokines analysis demonstrated low concentrations of TNF-α, IL-12, IL-4, and IL-10 in all the groups, and no statistical difference between them. The production of IL-6 could be better detected, and the experimental groups that consumed the probiotic showed significant lower levels of this cytokine.


The results suggest that L. rhamnosus intake, especially preventively, may avoid or decrease the development of candidiasis in immunosuppressed mice.

Clinical relevance

This work adds scientific evidences that probiotics intake can avoid the development of candidiasis.


Probiotics Candida Lactobacillus rhamnosus Cytokine 



The work was supported by Fundação de Amparo à Pesquisa de São Paulo (FAPESP).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Informed consent

For this type of study, formal consent was not required.


  1. 1.
    FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations/World Health Organization, LondonGoogle Scholar
  2. 2.
    Kumar M, Babaei P, Ji B, Nielsen J (2016) Human gut microbiota and healthy aging: recent developments and future prospective. Nutr Healthy Aging 4(1):3–16. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Iannitti T, Palmieri B (2010) Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 29(6):701–725. CrossRefPubMedGoogle Scholar
  4. 4.
    Al-Salami H, Caccetta R, Golocorbin-Kon S, Mikov M (2012). Probiotics applications in autoimmune diseases. In: Rigobelo EC(ed). Probiotics. InTech, Rijeka, pp 325–366Google Scholar
  5. 5.
    Shteyer E, Wilschanski M (2008) Novel therapeutic modalities in pediatric inflammatory bowel disease. Isr Med Assoc J 10(11):816–820 Scholar
  6. 6.
    Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27(3):2002–2009. Google Scholar
  7. 7.
    Richardson M, Rautemaa R (2009) How the host fights against Candida infections. Front Biosci (Schol Ed) (1):246–257., S1.
  8. 8.
    Pinto TMS, Neves ACC, Leão MVP, Jorge AOC (2008) Vinegar as an antimicrobial agent for control of Candida spp. in complete denture wearers. J Applied Oral Science (Online) 16(6):385–390. CrossRefGoogle Scholar
  9. 9.
    Querido SMR, Brito GN, Santos SSF, Leão MVP, Ito CYK, Jorge AOC (2011) Opportunistic microorganisms in patients undergoing antibiotic therapy for pulmonary tuberculosis. Braz J Microbiol 42(4):1321–1328. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Silva CRG, Oliveira LD, Leão MVP, Jorge AOC (2014) Candida spp. adherence to oral epithelial cells and levels of IgA in children with orthodontic appliances. Braz Oral Res 28(1):28–32. CrossRefGoogle Scholar
  11. 11.
    Shalev E, Battino S, Weiner E, Colodner R, Keness Y (1996) Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 5(10):593–596 Scholar
  12. 12.
    Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Korpela R (2007) Probiotics reduce the prevalence of oral Candida in the elderly—a randomized controlled trial. J Dent Res 86(2):125–130. CrossRefPubMedGoogle Scholar
  13. 13.
    Dos Santos AL, Jorge AOC, Santos SSF, Silva CRG, Leão MVP (2009) Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity. Braz J Microbiol 40(4):960–964. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mendonça FHBP, Santos SSF, Faria IS, Silva CRG, Jorge AOC, Leão MVP (2012) Effects of probiotics bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J 23(5):534–538. CrossRefPubMedGoogle Scholar
  15. 15.
    Villena J, Salva S, Agüero G, Alvarez S (2011) Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 55(6):434–445. CrossRefPubMedGoogle Scholar
  16. 16.
    Oliveira VM, Santos SS, Silva CR, Jorge AO, Leão MV (2016) Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans. J Appl Microbiol 121(6):1737–1744. CrossRefPubMedGoogle Scholar
  17. 17.
    Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4(4):303–306. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J (2009) Characterization of mucosal Candida albicans biofilms. PLoS One 4(11):e7967. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rossoni RD, Fuchs BB, de Barros PP, Velloso MD, Jorge AO, Junqueira JC, Mylonakis E (2017) Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. PLoS One 12(3):e0173332. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wagner RD, Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19(1):58. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Habil N, Murrani WA, Beal J, Foey AD (2011) Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner. Benef Micro 2(4):283–293. CrossRefGoogle Scholar
  22. 22.
    Gozalbo D, Maneu V, Gil ML (2014) Role of IFN-gamma in immune response to Candida albicans infections. Front Biosci (Landmark Ed) 19:1279–1290 Scholar
  23. 23.
    Zhang H, Chen H, Niu J, Wang Y, Xie L (2009) Role of adaptive immunity in the pathogenesis of Candida albicans keratitis. Invest Ophthalmol Vis Sci 50(6):2653–2659. CrossRefPubMedGoogle Scholar
  24. 24.
    Uddin MN, Siddig A, Oettinger CW, D’Souza MJ (2011) Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis. J Drug Target 19(9):752–760. CrossRefPubMedGoogle Scholar
  25. 25.
    Morgan DJ, Davis DM (2017) Distinct effects of dexamethasone on human natural killer cell responses dependent on cytokines. Front Immunol 8:432. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Samaranayake YH, Samaranayake LP (2001) Experimental oral candidiasis in animal models. Clin Microbiol Rev 14(2):398–429. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Metwalli KH, Khan SA, Krom BP, Jabra-Rizk MA (2013) Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation. PLoS Pathog 9(10):e1003616. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Traynor TR, Huffnagle GB (2001) Role of chemokines in fungal infections. Med Mycol 39:41–50. CrossRefPubMedGoogle Scholar
  29. 29.
    Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190(3):624–631. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Mariella Vieira Pereira Leão
    • 1
    Email author
  • Talita Angelina Aureliano Tavares
    • 2
  • Célia Regina Gonçalves e Silva
    • 1
  • Silvana Soleo Ferreira dos Santos
    • 1
  • Juliana Campos Junqueira
    • 2
  • Luciane Dias de Oliveira
    • 2
  • Antonio Olavo Cardoso Jorge
    • 2
  1. 1.Bioscience Basic InstituteUniversity of TaubatéTaubatéBrazil
  2. 2.Department of Biosciences and Oral Diagnosis, Institute of Science and TechnologyUniv. Estadual Paulista, UNESPSão José dos CamposBrazil

Personalised recommendations